Magnetic Resonance Imaging as an Early Indicator of Clinical Outcome in Patients With Metastatic Colorectal Carcinoma Treated With Cetuximab or Panitumumab

Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2012.07.001

Related search